Mobilizacija PBPC (progenitorskih ?elija iz periferne krvi) ne dovodi do direktne klini?ke koristi kod zdravih donora i treba je uzeti u obzir samo u cilju alogene transplantacije mati?nih ?elija.The carcinogenic likely of filgrastim solutions has not been researched. Filgrastim failed to induce bacterial gene mutations in possibly the existence or